登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式(希尔记法):
C21H26O3
化学文摘社编号:
分子量:
326.43
NACRES:
NA.24
PubChem Substance ID:
UNSPSC Code:
41116107
MDL number:
产品名称
布帕维酮, VETRANAL®, analytical standard
InChI
1S/C21H26O3/c1-21(2,3)14-10-8-13(9-11-14)12-17-18(22)15-6-4-5-7-16(15)19(23)20(17)24/h4-7,13-14,24H,8-12H2,1-3H3
SMILES string
CC(C)(C)C1CCC(CC1)CC2=C(O)C(=O)c3ccccc3C2=O
InChI key
KLLIVCPQDTYMLC-UHFFFAOYSA-N
grade
analytical standard
product line
VETRANAL®
technique(s)
HPLC: suitable
gas chromatography (GC): suitable
application(s)
forensics and toxicology
veterinary
format
neat
storage temp.
2-8°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Legal Information
VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany
Application
有关合适的仪器技术的更多信息,请参阅产品的分析证书。想要获得更多支持,请联系技术服务部。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Juliana Q Reimão et al.
Experimental parasitology, 130(3), 195-199 (2012-01-28)
The objective of this study was to develop a novel liposomal formulation, containing phosphatidylserine (PS), of buparvaquone (BPQ) and to evaluate its in vivo effectiveness in Leishmania (L.) infantum chagasi-infected hamsters. The activity of BPQ was evaluated against both the
G R Muraguri et al.
Research in veterinary science, 81(1), 119-126 (2005-11-18)
East Coast fever, caused by the protozoan parasite Theileria parva, kills about 600,000 cattle annually in Africa. The hydroxynaphthoquinone compound buparvaquone (BPQ) is curative. Sixteen calves were infected with T. parva. On manifestation of disease symptoms, eight were injected with
Gantala Venkatesh et al.
Drug development and industrial pharmacy, 36(6), 735-745 (2010-02-09)
The aim of this study was to prepare a lipid-based self-microemulsifying drug delivery system (SMEDDS) to increase the solubility and oral bioavailability of a poorly water-soluble compound, buparvaquone (BPQ). The solubility of BPQ was determined in various vehicles, and pseudo-ternary
Tracy Garnier et al.
The Journal of pharmacy and pharmacology, 59(1), 41-49 (2007-01-18)
As the part of a study to develop buparvaquone (BPQ) formulations for the treatment of cutaneous leishmaniasis, the topical delivery of BPQ and one of its prodrugs from a range of formulations was evaluated. In previous studies, BPQ and its
Bariş Saruhan et al.
Turkiye parazitolojii dergisi, 32(4), 317-321 (2009-01-22)
The aim of this study was to examine the efficacy of buparvaquone (Buparvon, ALKE, Istanbul) in the treatment of theileriosis in cattle. The causative agent T. annulata causes direct and indirect gross economical loss in Turkey. Theileriosis was microscopically diagnosed
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持